Sign up to save your podcasts
Or
Share Efficacy of Virologically Suppressed Adults With HIV Switching From B/F/TAF to Dolutegravir/3TC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Efficacy of Virologically Suppressed Adults With HIV Switching From B/F/TAF to Dolutegravir/3TC
In this podcast, Charlotte M. Rolle, MD, MPH, discusses her team's research that evaluated the efficacy and safety of switching HIV treatment using bictegravir/emtricitabine/tenofovir alafenamide to dolutegravir/lamivudine. Dr Rolle spoke about this topic during her poster presentation at IDWeek 2023 in Boston, Massachusetts.
View all episodes
By Consultant360
4
66 ratings
In this podcast, Charlotte M. Rolle, MD, MPH, discusses her team's research that evaluated the efficacy and safety of switching HIV treatment using bictegravir/emtricitabine/tenofovir alafenamide to dolutegravir/lamivudine. Dr Rolle spoke about this topic during her poster presentation at IDWeek 2023 in Boston, Massachusetts.
More shows like Podcasts360
View all
Mayo Clinic Talks
278 Listeners
The Curbsiders Internal Medicine Podcast
3,327 Listeners
Core IM | Internal Medicine Podcast
1,112 Listeners
The Rx Bricks Podcast
115 Listeners
The Pickle Jar Podcast - Adrenal Insufficiency
27 Listeners